Bio Green Med Solution (BGMS) EBT Margin Growth (3y) (2013 - 2026)
Analysis
Bio Green Med Solution (BGMS) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.56 Bn | 133.71 Bn | 2.84 Bn | -484.00 |
| 2 | Regeneron Pharmaceuticals | 87.63 Bn | 79.64 Bn | 3.93 Bn | 132.00 |
| 3 | Argenx Se | 64.65 Bn | 59.46 Bn | 1.37 Bn | 6,685.00 |
| 4 | Moderna | 60.24 Bn | 55.10 Bn | 52.00 Mn | -2,054.00 |
| 5 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - | - |
| 6 | BeOne Medicines | 40.46 Bn | 35.36 Bn | 1.53 Bn | 8,006.00 |
| 7 | Alnylam Pharmaceuticals | 35.86 Bn | 32.56 Bn | 992.69 Mn | 9,980.00 |
| 8 | Royalty Pharma | 28.00 Bn | 27.16 Bn | - | -5,319.00 |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 31,363.00 |
| 10 | Bio Green Med Solution | 4.68 Mn | 886,595.10 | 79,000.00 | 149,984.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 149,984.00 |
| Dec 31, 2018 | -67,362.00 |
| Dec 31, 2016 | 17,356.00 |
| Sep 30, 2016 | 20,101.00 |
| Jun 30, 2016 | -209,029.00 |
| Mar 31, 2016 | -95,943.00 |
| Dec 31, 2015 | 10.04 Mn |
| Sep 30, 2015 | 895,427.00 |
| Jun 30, 2015 | 1.22 Mn |
| Mar 31, 2015 | 73,135.00 |
| Dec 31, 2014 | -30,921.00 |
| Sep 30, 2014 | 130,480.00 |
| Jun 30, 2014 | 60,642.00 |
| Mar 31, 2014 | 111,381.00 |
| Dec 31, 2013 | -184,924.00 |
| Sep 30, 2013 | 62,473.00 |
| Jun 30, 2013 | 397,105.00 |